Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFIA: Neoadjuvant Fulvestrant +/- Palbociclib in Luminal Breast Cancer
NCT03447132Phase 3Completed
- Sponsor
- International Cancer Research Group
- Start
- Dec 2017
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of palbociclib in breast cancer, sponsored by International Cancer Research Group. Started Dec 2017; status: completed.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03447132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03447132.